Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 2 | 89% | 12% | 89% | 12% |
Total | 2 | 89% | 12% | 89% | 12% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 33% | Spiked |
Estimated Values | 2 | 33% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 6 | . | |
False Negatives | 4 | 67% | 4 out of 6 |
Not Spiked | 13 | . | |
False Positives | 0 | 0% | 0 out of 12 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 6 | 74% | 30% | 68% | 36% |
Total | 6 | 74% | 30% | 68% | 36% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 6 | 55% | Spiked |
Estimated Values | 3 | 27% | Spiked |
Deleted Values | 2 | 11% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 5 | 45% | 5 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 6 |
BQS OBSP Determination: |
17-ALPHA-ETHYNYLESTRADIOL |
METHOD: 6434 , TESTIDCODE: 63207GM006 |
Open Data Set |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 2 | 74% | 31% | 74% | 32% |
Total | 2 | 74% | 31% | 74% | 32% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 18% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 9 | 82% | 9 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 3 | 87% | 30% | 81% | 44% |
Total | 3 | 87% | 30% | 81% | 44% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 3 | 27% | Spiked |
Estimated Values | 1 | 9% | Spiked |
Deleted Values | 2 | 11% | Spiked + Not Spiked |
Spiked, Censored | 1 | 9% | Spiked |
Spiked | 12 | . | |
False Negatives | 7 | 64% | 7 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 6 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 9 | 52% | 16% | 54% | 15% |
Total | 9 | 52% | 16% | 54% | 15% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 9 | 82% | Spiked |
Estimated Values | 4 | 36% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 2 | 18% | 2 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 1 | 159% | . | 159% | 0% |
Total | 1 | 159% | . | 159% | 0% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 1 | 20% | Spiked |
Estimated Values | 1 | 20% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 3 | 60% | Spiked |
Spiked | 6 | . | |
False Negatives | 1 | 20% | 1 out of 5 |
Not Spiked | 13 | . | |
False Positives | 1 | 8% | 1 out of 13 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 4 | 153% | 103% | 103% | 79% |
Total | 4 | 153% | 103% | 103% | 79% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 4 | 36% | Spiked |
Estimated Values | 4 | 36% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 7 | 64% | 7 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 5 | 114% | 11% | 116% | 9% |
Total | 5 | 114% | 11% | 116% | 9% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 5 | 42% | Spiked |
Estimated Values | 1 | 8% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 2 | 17% | Spiked |
Spiked | 12 | . | |
False Negatives | 5 | 42% | 5 out of 12 |
Not Spiked | 7 | . | |
False Positives | 2 | 33% | 2 out of 6 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 55% | 7% | 55% | 7% |
>= Reporting Level | 4 | 54% | 2% | 53% | 2% |
Total | 6 | 54% | 4% | 53% | 3% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 6 | 50% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 5 | 42% | Spiked |
Spiked | 12 | . | |
False Negatives | 1 | 8% | 1 out of 12 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 6 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 97% | 32% | 97% | 34% |
Total | 2 | 97% | 32% | 97% | 34% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 33% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 4 | 67% | Spiked |
Spiked | 6 | . | |
False Negatives | 0 | 0% | 0 out of 6 |
Not Spiked | 13 | . | |
False Positives | 0 | 0% | 0 out of 12 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 10 | 70% | 40% | 57% | 24% |
Total | 10 | 70% | 40% | 57% | 24% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 10 | 83% | Spiked |
Estimated Values | 3 | 25% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 2 | 17% | 2 out of 12 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 6 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 4 | 117% | 98% | 100% | 116% |
Total | 4 | 117% | 98% | 100% | 116% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 4 | 36% | Spiked |
Estimated Values | 3 | 27% | Spiked |
Deleted Values | 2 | 11% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 7 | 64% | 7 out of 11 |
Not Spiked | 7 | . | |
False Positives | 2 | 33% | 2 out of 6 |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | 0% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 1 | 9% | Spiked |
Spiked | 12 | . | |
False Negatives | 10 | 91% | 10 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 2 | 85% | 48% | 85% | 50% |
Total | 2 | 85% | 48% | 85% | 50% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 20% | Spiked |
Estimated Values | 1 | 10% | Spiked |
Deleted Values | 2 | 11% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 8 | 80% | 8 out of 10 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 4 | 78% | 36% | 73% | 41% |
Total | 4 | 78% | 36% | 73% | 41% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 4 | 33% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 2 | 17% | Spiked |
Spiked | 12 | . | |
False Negatives | 6 | 50% | 6 out of 12 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 6 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 1 | 60% | . | 60% | 0% |
Total | 1 | 60% | . | 60% | 0% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 1 | 9% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 1 | 9% | Spiked |
Spiked | 12 | . | |
False Negatives | 9 | 82% | 9 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 3 | 72% | 46% | 60% | 67% |
Total | 3 | 72% | 46% | 60% | 67% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 3 | 27% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 12 | . | |
False Negatives | 8 | 73% | 8 out of 11 |
Not Spiked | 7 | . | |
False Positives | 0 | 0% | 0 out of 7 |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | 0% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 5 | 26% | Spiked + Not Spiked |
Spiked, Censored | 7 | 88% | Spiked |
Spiked | 12 | . | |
False Negatives | 1 | 13% | 1 out of 8 |
Not Spiked | 7 | . | |
False Positives | 1 | 17% | 1 out of 6 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 1 | 194% | . | 194% | 0% |
Total | 1 | 194% | . | 194% | 0% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 1 | 20% | Spiked |
Estimated Values | 1 | 20% | Spiked |
Deleted Values | 1 | 5% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 6 | . | |
False Negatives | 4 | 80% | 4 out of 5 |
Not Spiked | 13 | . | |
False Positives | 1 | 8% | 1 out of 13 |
BQS OBSP Determination: |
TRANS-DIETHYLSTILBESTROL |
METHOD: 6434 , TESTIDCODE: 63620GM006 |
Open Data Set |